Enzolytics Inc (ENZC)

[bankjob]

‘AZD7442 was optimized using AstraZeneca’s proprietary YTE half-life extension technology, which could afford up to 12 months of protection from COVID-19, and is delivered by intramuscular injection.’

https://finance.yahoo.com/news/azd7442-provent-phase-iii-prophylaxis-110000609.html?fr=sycsrp_catchall

Potentially promising in ways, but sounds more like a deterrent than a neutralizer. Will possibly be prone to resistance by viruses due to virus escape. That’s where the identification of HIV and COVID-19 immutable sites, and subsequent patenting of, is going to most likely reap huge benefits and positive results for ENZC.